Joan Collins (Dublin South Central, Independents 4 Change) | Oireachtas source

Back in 2017 Orkambi was reimbursed for market distribution here in Ireland and it was a great boost for the cystic fibrosis, CF, community after a long campaign. A new drug, Kaftrio, has been approved in the USA and by the European Medicines Agency, EMA, in April of this year. I tabled a question to the Minister for Health in early May and I was told the applicants had put in the rapid review dossier for the drug. I flagged this with the Tánaiste yesterday because I hope the CF community will get some clarity today on when the Health Products Regulatory Authority, HPRA, will reimburse the drug and market it.

See this speech in context